Plant-Derived Nanovesicles as a Cross-Kingdom Therapeutic Approach for T2DM and Related Metabolic Disorders: Current Evidence and Future Perspectives.

Yu Y, Shan Y, Chen Y, Ding L, Qian H.

Open source

DOI
10.1021/acs.jafc.6c05063
Published
2026-09-01
Container
J Agric Food Chem
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.jafc.6c05063,
  title = {Plant-Derived Nanovesicles as a Cross-Kingdom Therapeutic Approach for T2DM and Related Metabolic Disorders: Current Evidence and Future Perspectives.},
  author = {Yu Y and  Shan Y and  Chen Y and  Ding L and  Qian H.},
  year = {2026},
  journal = {J Agric Food Chem},
  doi = {10.1021/acs.jafc.6c05063},
  url = {https://doi.org/10.1021/acs.jafc.6c05063}
}

RIS

TY  - JOUR
TI  - Plant-Derived Nanovesicles as a Cross-Kingdom Therapeutic Approach for T2DM and Related Metabolic Disorders: Current Evidence and Future Perspectives.
AU  - Yu Y
AU  -  Shan Y
AU  -  Chen Y
AU  -  Ding L
AU  -  Qian H.
PY  - 2026
JO  - J Agric Food Chem
DO  - 10.1021/acs.jafc.6c05063
UR  - https://doi.org/10.1021/acs.jafc.6c05063
ER  - 

APA

Y, Y., Y, S., Y, C., L, D., & H., Q. (2026). Plant-Derived Nanovesicles as a Cross-Kingdom Therapeutic Approach for T2DM and Related Metabolic Disorders: Current Evidence and Future Perspectives.. J Agric Food Chem. https://doi.org/10.1021/acs.jafc.6c05063

Source records